Clinical Trial Update: Sofosbuvir and Daclatasvir in Treating Hepatitis C, A Study on 1000 Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Sofosbuvir and Daclatasvir in 1000 Hepatitis C patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daclatasvir (daclatasvir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED